Business Description
SymBio Pharmaceuticals Ltd
ISIN : JP3383050006
Description
SymBio Pharmaceuticals Ltd is a biopharmaceutical company engaged in manufacturing and commercializing drugs for oncology, hematology, and pain management.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.91 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.37 | |||||
Beneish M-Score | -4.42 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.6 | |||||
3-Year EBITDA Growth Rate | 49 | |||||
3-Year EPS without NRI Growth Rate | 33.3 | |||||
3-Year FCF Growth Rate | 56.4 | |||||
3-Year Book Growth Rate | 11.9 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 73.29 | |||||
9-Day RSI | 64.57 | |||||
14-Day RSI | 59.7 | |||||
6-1 Month Momentum % | -35.42 | |||||
12-1 Month Momentum % | -64.04 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 10.68 | |||||
Quick Ratio | 10.43 | |||||
Cash Ratio | 9.16 | |||||
Days Inventory | 126.08 | |||||
Days Sales Outstanding | 74.51 | |||||
Days Payable | 20.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.4 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 78.38 | |||||
Operating Margin % | -35.96 | |||||
Net Margin % | -59.12 | |||||
FCF Margin % | -9.21 | |||||
ROE % | -35.37 | |||||
ROA % | -31.99 | |||||
ROIC % | -139 | |||||
ROC (Joel Greenblatt) % | -148.71 | |||||
ROCE % | -21.51 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.59 | |||||
PB Ratio | 1.16 | |||||
Price-to-Tangible-Book | 1.16 | |||||
EV-to-EBIT | -1.05 | |||||
EV-to-EBITDA | -1.05 | |||||
EV-to-Forward-EBITDA | 11.75 | |||||
EV-to-Revenue | 0.38 | |||||
EV-to-Forward-Revenue | 1.96 | |||||
EV-to-FCF | -4.08 | |||||
Price-to-Median-PS-Value | 0.43 | |||||
Price-to-Net-Current-Asset-Value | 1.17 | |||||
Price-to-Net-Cash | 1.39 | |||||
Earnings Yield (Greenblatt) % | -95.24 | |||||
FCF Yield % | -5.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SymBio Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 4,642.76 | ||
EPS (TTM) (円) | -67.33 | ||
Beta | -0.05 | ||
Volatility % | 26.92 | ||
14-Day RSI | 59.7 | ||
14-Day ATR (円) | 9.482842 | ||
20-Day SMA (円) | 169.75 | ||
12-1 Month Momentum % | -64.04 | ||
52-Week Range (円) | 146 - 437 | ||
Shares Outstanding (Mil) | 45.81 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
SymBio Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
SymBio Pharmaceuticals Ltd Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
SymBio Pharmaceuticals Ltd Frequently Asked Questions
What is SymBio Pharmaceuticals Ltd(TSE:4582)'s stock price today?
The current price of TSE:4582 is 円181.00. The 52 week high of TSE:4582 is 円437.00 and 52 week low is 円146.00.
When is next earnings date of SymBio Pharmaceuticals Ltd(TSE:4582)?
The next earnings date of SymBio Pharmaceuticals Ltd(TSE:4582) is .
Does SymBio Pharmaceuticals Ltd(TSE:4582) pay dividends? If so, how much?
SymBio Pharmaceuticals Ltd(TSE:4582) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |